Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience

被引：3

作者：

Alkhaldi, Hanan ^{[1
,2
]}

Goloubeva, Olga ^{[1
]}

Rapoport, Aaron P. ^{[1
,2
]}

Dahiya, Saurabh ^{[1
,2
]}

Pang, Yifan ^{[3
]}

Ali, Moaath Mustafa ^{[1
,2
]}

Hardy, Nancy M. ^{[1
,2
]}

Mohindra, Pranshu ^{[1
,2
]}

Bukharia, Ali ^{[1
,2
]}

Lutfia, Forat ^{[1
,2
]}

Sanchez-Petitto, Gabriela ^{[1
,2
]}

Molitoris, Jason ^{[1
,2
]}

Samanta, Santanu ^{[1
,2
]}

Li, Xin ^{[1
]}

Toth, Tara ^{[1
]}

Landau, Mindy ^{[1
]}

Hodges, Susan ^{[1
]}

Nishioka, Jennifer ^{[1
]}

Ruehle, Kathleen ^{[1
]}

Ridge, Linda ^{[1
]}

Gahres, Natalie ^{[1
]}

Kocoglu, Mehmet H. ^{[1
,2
]}

Atanackovic, Djordje ^{[1
,2
]}

Malinou, Justin N. ^{[1
,2
]}

Yared, Jean A. ^{[1
,2
,4
]}

机构：

[1] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[2] Univ Maryland, Dept Med, Sch Med, Baltimore, MD USA

[3] NHLBI, NIH, Bethesda, MD USA

[4] Univ Maryland, Greenebaum Comprehens Canc Ctr, 22 S Greene St, Baltimore, MD 21201 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2023年 / 55卷 / 01期

关键词：

ACUTE MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; LOW-DOSE TBI; EUROPEAN GROUP; WORKING PARTY; BLOOD; MALIGNANCIES; MORTALITY; AML;

D O I：

10.1016/j.transproceed.2022.10.061

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background. Reduced intensity conditioning (RIC) regimens decrease the risk for nonrelapse mortality (NRM) in adult patients undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies but increase the risk for relapse. The aim of this study was to compare the outcomes of fludarabine-total body irradiation (TBI) with fludarabine among patients with hematologic diseases. Patients and Methods. This retrospective study of 137 patients with different hematologic malignancies compared the outcomes of 63 patients who received a conventional RIC regimen with 2 days of IV busulfan (3.2 mg/kg/d pound 2 days) and fludarabine with 74 patients who received the same regimen plus 400 cGy of fludarabine and busulfan (FB)-TBI divided in 2 doses over 1 day (200 cGy BID). Median follow-up was 4.62 years. Results. The donors were either HLA-matched siblings (36%) or HLA-matched unrelated donors (64%). The FB-TBI showed trends toward improvement in progression-free survival (PFS) and overall survival (OS) over FB (5-year PFS rates 50% vs 34%, P = .06, and 5-year OS rate 53% vs 39%, P = .13). Acute graft-vs-host disease (aGVHD), relapse, and NRM were similar between the 2 groups. The 5-year cumulative incidence of chronic GVHD (cGVHD) was lower in the FB-TBI group compared with the FB group (29% vs 52%, P = .003). Multivariable analysis revealed that grade III-IV aGVHD was the only independent risk factor for worse OS (P = .001) in both groups. A high disease risk index was possibly associated with inferior OS (P = .07) in both groups. Conclusions. The FB-TBI is a safe and effective intensified RIC regimen for adult patients with hematologic malignancies. It predicted a lower risk for cGVHD and showed possibly improved PFS and OS compared with FB.

引用

页码：214 / 224

页数：11

共 50 条

[41] Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT) [J].

Le Bourgeois, Amandine ;

Lestang, Elsa ;

Guillaume, Thierry ;

Delaunay, Jacques ;

Ayari, Sameh ;

Blin, Nicolas ;

Clavert, Aline ;

Tessoulin, Benoit ;

Dubruille, Viviane ;

Mahe, Beatrice ;

Roland, Virginie ;

Gastinne, Thomas ;

Le Gouill, Steven ;

Moreau, Philippe ;

Mohty, Mohamad ;

Planche, Lucie ;

Chevallier, Patrice .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (03) :177-186

[42] Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation [J].

Nakane, Takahiko ;

Nakamae, Hirohisa ;

Koh, Hideo ;

Nakamae, Mika ;

Hayashi, Yoshiki ;

Nishimoto, Mitsutaka ;

Yoshimura, Takuro ;

Inoue, Eri ;

Inoue, Atsushi ;

Aimoto, Ran ;

Aimoto, Mizuki ;

Terada, Yoshiki ;

Koh, Ki-Ryang ;

Yamane, Takahisa ;

Hino, Masayuki .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (04) :509-516

[43] Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation [J].

de Souza, Jonas A. ;

Saliba, Rima M. ;

Patah, Poliana ;

Rondon, Gabriela ;

Ribeiro, Rachel ;

Silva, Leandro de Padua ;

Qazilbash, Muzaffar H. ;

Hosing, Chitra ;

Popat, Uday ;

Efebera, Yvonne ;

Champlin, Richard E. ;

de Lima, Marcos .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) :1094-1099

[44] Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes [J].

Alatrash, Gheath ;

Saberian, Chantal ;

Bassett, Roland ;

Thall, Peter F. ;

Ledesma, Celina ;

Lu, Yoshimi ;

Daher, May ;

Valdez, Benigno C. ;

Kawedia, Jitesh ;

Popat, Uday ;

Mehta, Rohtesh ;

Oran, Betul ;

Nieto, Yago ;

Olson, Amanda ;

Anderlini, Paolo ;

Marin, David ;

Hosing, Chitra ;

Alousi, Amin M. ;

Shpall, Elizabeth J. ;

Rondon, Gabriela ;

Chen, Julianne ;

Qazilbash, Muzaffar ;

Champlin, Richard E. ;

Kebriaei, Partow .

TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08) :501.e1-501.e7

[45] Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia [J].

Mora, Elvira ;

Montoro, Juan ;

Balaguer, Aitana ;

Rovira, Montserrat ;

Cabrero, Monica ;

Heras, Inmaculada ;

Ribera, Josep-Maria ;

Antelo, Gabriela ;

Martin, Ana Africa ;

Godino, Oriana Lopez ;

Torrent, Anna ;

Villalba, Marta ;

Chorao, Pedro ;

Sanz, Miguel A. ;

Sanz, Jaime .

BONE MARROW TRANSPLANTATION, 2024, 59 (08) :1137-1145

[46] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation [J].

Banet, Anne ;

Bazarbachi, Ali ;

Labopin, Myriam ;

Stocker, Nicolas ;

Dulery, Remy ;

Malard, Florent ;

Van de Wyngaert, Zoe ;

Genthon, Alexis ;

Memoli, Mara ;

Legrand, Ollivier ;

Bonnin, Agnes ;

Ledraa, Tounes ;

Belhocine, Ramdane ;

Sestili, Simona ;

El-Cheikh, Jean ;

Mohty, Mohamad ;

Brissot, Eolia .

BONE MARROW TRANSPLANTATION, 2023, 58 (01) :61-67

[47] Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC [J].

Pena, M. ;

Martinez, D. F. ;

Paviglianiti, A. ;

Balaguer, A. ;

Sanz, J. ;

Pascual, M. J. ;

Herruzo, B. ;

Solano, C. ;

Benzaquen, A. ;

Salas, M. Q. ;

Rovira, M. ;

Nieto, A. ;

Espanol, I. ;

Huguet, M. ;

Bento, L. ;

Saez, A. J. ;

Mussetti, A. .

BONE MARROW TRANSPLANTATION, 2025, 60 (06) :795-803

[48] A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia [J].

Gergis, Usama ;

Roboz, Gail ;

Shore, Tsiporah ;

Ritchie, Ellen ;

Mayer, Sebastian ;

Wissa, Usama ;

McKenna, Marshall ;

Christos, Paul ;

Pearse, Roger ;

Mark, Tomer ;

Scandura, Joseph ;

van Besien, Koen ;

Feldman, Eric .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) :1040-1045

[49] Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis [J].

Braitsch, Krischan ;

Schwarz, Alix ;

Koch, Katrin ;

Hubbuch, Mara ;

Menzel, Helge ;

Keller, Ulrich ;

Goetze, Katharina S. ;

Bassermann, Florian ;

Herhaus, Peter ;

Verbeek, Mareike .

ANNALS OF HEMATOLOGY, 2022, 101 (06) :1311-1319

[50] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia [J].

Krejci, Marta ;

Doubek, Michael ;

Brychtova, Yvona ;

Stehlikova, Olga ;

Chovancova, Jana ;

Tichy, Boris ;

Francova, Hana Skuhrova ;

Navratil, Milan ;

Tomiska, Miroslav ;

Horky, Ondrej ;

Pospisilova, Sarka ;

Mayer, Jiri .

ANNALS OF HEMATOLOGY, 2013, 92 (02) :249-254

← 1 2 3 4 5 →